Paul, Fundamental immunology Chapter 8, Raven Press NY, p. 242, 1993.* |
Riechmann et al., Nature 332:323-327, 1988.* |
Jain, Sci. Amer. 271:58, 1994.* |
Chatterjee et al., Cancer Immunol. Immunother. 38:75-82, 1994.* |
Gura, Science 278:1041-1042, 1997.* |
Knight., Bio Technology 7, No. 1, 1989.* |
Greenspan et al., Nature Biotechnology 17:936-937, 1999.* |
Goto, et al., “A Novel Membrane Antigen Selectively Expressed on Terminally Differentiated Human B Cells,” Blood, col. 84, No. 6, 1922-1930 (1994). |
Ozaki, et al., “Localization and Imaging of Human Plasmacytoma Xenografts in Severe Combined Immunodeficiency Mice by a New Murine Monoclonal Antibody, ANTI-HM1.24,” Tokushima Jouranl of Experimental Medicine, vol. 43, 7-15 (1996). |
Ozaki, et al., “Immunotherapy of Multiple Myeloma With a Monoclonal Antibody Directed Against a Plasma Cell-Specific Antigen, HM1.24,” Blook, vol. 90, No. 8, 3179-3186 (1997). |
Ozaki et al.; “Localization and Imaging of Human Plasmacytoma Xenografts in Severe Combined Immunodeficiency Mice by A New Murine Monoclonal Antibody, Anti-HM1.24”, Radiolocalization of Human Plasmacytoma; Tokushima Journal of Experimental Medicine; vol. 43; 1996 pp. 7-15; XP002912306. |
Chatterjee et al.; “Idiotypic Antibody Immunotheraphy of Cancer”; Immunotherapy; Springer-Verlag; vol. 38; 1994; pp. 75-82. |
Paul et al.; Fundamental Immunology; Raven Press NY; 1993; p242. |
Jain; “Barriers to Drug Delivery in Solid Tumors”; Scientific American; vol. 271, No. 1; Jul. 1994; pp. 58-65. |
Gura Cancer Models; “System for Identifying New Drugs Are Often Faulty”; Science; vol. 278; Nov. 7, 1997; pp. 1041-1042. |
Knight; “The Carbohydrate Frontier”; Biotechnology Nature Publishing; vol. 7, No. 1; Jan. 1989; 4 Sheets. |
Greenspan et al.; “Defining Epitopes: It's Not As Easy As It Seems”; Nature Biotechnology; vol. 17; Oct. 1999; pp. 236-237. |